ICARNK
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

ICARNK Trademark

Serial Number: 97318048

ICARNK is a trademark filed by GRACELL BIOSCIENCE (SHANGHAI) CO.,LTD. on March 17, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

GRACELL BIOSCIENCE (SHANGHAI) CO.,LTD. (20 trademarks)

ROOM 403, FLOOR 4,BUILDING 9,NO. 471
SHANGHAI, , CN

Entity Type: 11

Gracell Biotechnology Co.,Ltd (14 trademarks)

Level 12,Building 1,No.926 Yishan Road,
Shanghai 200000 , CN

Entity Type: 99

Trademark Details

Filing Date

March 17, 2022

Registration Date

Not Registered

Published for Opposition

November 1, 2022

Goods & Services

Bacteriological culture mediums; Biological preparations for the treatment of cancer; Biological tissue cultures for medical purposes; Cellular function activating agents for medical purposes; Diagnostic biomarker reagents for medical purposes; Dietetic preparations adapted for medical purposes; Gases for medical and dental use; Living cells for medical use; Nutritive substances for microorganisms for medical purposes; Stem cells for medical purposes

Genetic testing for medical purposes; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical and pharmaceutical consultation; Medical assistance services; Medical consultations; Medical information; Medical testing services relating to the diagnosis and treatment of disease; Nutritional therapy services; Providing medical information; Stem cell therapy services

Biochemical research and analysis; Biological research; Biomedical research services; Medical and scientific research in the field of cancer treatment and diagnosis; Pharmaceutical drug development services; Pharmaceutical product evaluation; Research and development services in the field of antibodies; Scientific research in the nature of conducting clinical trials for others; Stem cell research services; Structural and functional analysis of genomes

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jul 28, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jul 28, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 2, 2025 EXRA
SOU EXTENSION 4 GRANTED
Apr 1, 2025 EX4G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 28, 2025 AITU
SOU EXTENSION 4 FILED
Dec 14, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Dec 14, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 25, 2024 EXRA
SOU EXTENSION 3 GRANTED
Jun 25, 2024 EX3G
SOU EXTENSION 3 FILED
Jun 25, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 24, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 26, 2023 EXRA
SOU EXTENSION 2 GRANTED
Dec 22, 2023 EX2G
SOU EXTENSION 2 FILED
Dec 22, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 22, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 22, 2023 EXRA
SOU EXTENSION 1 GRANTED
Jun 20, 2023 EX1G
SOU EXTENSION 1 FILED
Jun 20, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 20, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 27, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 1, 2022 NPUB
PUBLISHED FOR OPPOSITION
Nov 1, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 12, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 27, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 23, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 23, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 23, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 23, 2022 CNEA
ASSIGNED TO EXAMINER
Sep 23, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 23, 2022 NWOS
NEW APPLICATION ENTERED
Mar 21, 2022 NWAP